Topics

Sobi to acquire emapalumab drug from Novimmune

19:00 EDT 12 Jun 2019 | Pharmaceutical Technology

Swedish Orphan Biovitrum (Sobi) has agreed to buy a newly established firm from Novimmune for a consideration of SEK4,897m ($517.9m)....
Read More...

The post Sobi to acquire emapalumab drug from Novimmune appeared first on Pharmaceutical Technology.

Original Article: Sobi to acquire emapalumab drug from Novimmune

NEXT ARTICLE

More From BioPortfolio on "Sobi to acquire emapalumab drug from Novimmune"

Quick Search